AwardedCzechiaGoodsCZK 20,300,691
LP s obsahem BRENTUXIMABU VEDOTIN 2024
- Published
- Published 3 December 2024
- Deadline
- Closed 16 January 2025
Overview
Předmětem veřejné zakázky jsou opakující se dodávky léčivých přípravků s obsahem účinné látky BRENTUXIMAB VEDOTIN
Key details
- Country
- Czechia
- Status
- Awarded
- Category
- Goods
- Estimated value
- CZK 20,300,691
- Procedure
- Open
- SME suitable
- Yes
- Published
- 3 December 2024
- Deadline
- Closed
Antineoplastic and immunomodulating agents
Award outcome
- Awarded value
- CZK 22,292,197
- Award date
- 7 February 2025
- Contract period
- 21 May 2025 → 5 May 2028
- Takeda Pharmaceuticals Czech Republic s.r.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
21 February 2025
Contract Notice
13 December 2024
Contract Notice
3 December 2024
Contracting authority
Fakultní nemocnice Olomouc
Procuring entityOlomouc - Nová Ulice, Czechia
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.